Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 2016 Mar 21;81(5):1005. doi: 10.1111/bcp.12933

Retraction: ‘rhBNP therapy can improve clinical outcomes and reduce in‐hospital mortality compared with dobutamine in heart failure patients: a meta‐analysis’ by Ming‐Yi Lv, Shu‐Ling Deng and Xiao‐Feng Long

PMCID: PMC4834584  PMID: 27086732

Abstract

The above article, published online on 28th November 2015 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1111/bcp.12788/full), and in volume 81, pp. 174–185, has been retracted by agreement between the authors, the journal Editor in Chief, Professor A Cohen, and John Wiley & Sons Limited. The retraction has been agreed owing to evidence indicating that the peer review of this paper was compromised. The authors were unaware of the actions of the third party responsible for compromising the peer review.

Reference

  1. Lv M‐Y, Deng S‐L, Long X‐F. rhBNP therapy can improve clinical outcomes and reduce in‐hospital mortality compared with dobutamine in heart failure patients: a meta‐analysis. Br J Clin Pharmacol 2016; 81: 174–85. doi:10.1111/bcp.12788. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES